Testing effectiveness (Phase 2)WithdrawnNCT00346502
What this trial is testing
Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)
Who this might be right for
Dysplastic Nevus Syndrome
University of Illinois at Chicago